These data showed that ovarian cancers seem to resemble colorectal cancers from LS carriers, which are associated with higher stage-specific survival [44] and fewer TP53 and BRAF abnormalities compared to sporadic tumors [45] and PIK3CA mutations in about 20% of cases [46]. This evidence concerns the gene PIK3CA and ovarian cancer.